Primary tabs
The list of publications is indicative and may not include all publications.
Increased augmentation index is paradoxically associated with lower in-hospital mortality in patients with acute ischemic stroke..
Atherosclerosis. 236(1), 150-3.
(2014).
Lipid-lowering agents in the management of nonalcoholic fatty liver disease..
World J Hepatol. 6(10), 738-44.
(2014).
Type 2 diabetes is associated with a worse functional outcome of ischemic stroke..
World J Diabetes. 5(6), 939-44.
(2014).
The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome..
Clin Endocrinol (Oxf). 80(3), 432-8.
(2014).
Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness..
J Am Soc Hypertens. 8(2), 74-82.
(2014).
Uterine volume and endometrial thickness in the early follicular phase in patients with polycystic ovary syndrome..
Endocr Pract. 20(6), 540-7.
(2014).
Combined chelation therapy with deferoxamine and deferiprone in β-thalassemia major: compliance and opinions of young thalassemic patients..
Hemoglobin. 38(2), 111-4.
(2014).
Predictive value of the ankle brachial index in patients with acute ischemic stroke..
Vasa. 43(1), 55-61.
(2014).
Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients..
J Clin Hypertens (Greenwich). 16(4), 309-12.
(2014).
Predictive factors that influence the course of medullary thyroid carcinoma..
Int J Clin Oncol. 19(3), 445-51.
(2014).
Antidiabetic treatment, stroke severity and outcome..
World J Diabetes. 5(2), 84-8.
(2014).
Public awareness of stroke symptoms and risk factors and response to acute stroke in Northern Greece..
Int J Stroke. 9(4), E15.
(2014).
Novel data on the pathogenesis of atherosclerosis, treatment targets, and new therapeutic interventions in lipid-related cardiovascular risk factors..
Curr Pharm Des. 20(40), 6215-9.
(2014).
Effects of lipid-lowering agents on inflammation, haemostasis and blood pressure..
Curr Pharm Des. 20(40), 6306-13.
(2014).
Impact of periampullary diverticula on the outcome and fluoroscopy time in endoscopic retrograde cholangiopancreatography..
Hepatobiliary Pancreat Dis Int. 12(4), 408-14.
(2013).
Prevalence of metabolic syndrome in women with polycystic ovary syndrome..
Clin Endocrinol (Oxf). 78(4), 586-92.
(2013).
Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome..
World J Hepatol. 5(11), 621-6.
(2013).
Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome..
Eur J Endocrinol. 168(2), 145-52.
(2013).
Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome..
Hormones (Athens). 12(4), 559-66.
(2013).
The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study..
Curr Vasc Pharmacol. 11(5), 779-84.
(2013).
Calcitonin stimulation tests for the early diagnosis and follow-up of patients with C cell disease: a descriptive analysis..
Hippokratia. 17(3), 246-51.
(2013).
Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome..
Gynecol Endocrinol. 29(3), 250-3.
(2013).
Pages
- « πρώτη
- ‹ προηγούμενη
- …
- 2
- 3
- 4
- 5
- 6
- …
- επόμενη ›
- τελευταία »